METASTATIC MELANOMA

METASTATIC MELANOMA IS THE DEADLIEST FORM OF MELANOMA, WITH AN ESTIMATED 76,380 NEW CASES EXPECTED TO BE DIAGNOSED IN THE U.S. IN 2016. THE INCIDENCE OF MELANOMA HAS BEEN INCREASING FOR AT LEAST 30 YEARS, REINFORCING THE NEED FOR EFFECTIVE TREATMENT OPTIONS TO FIGHT THIS DEADLY DISEASE.



HOWEVER, CANCER EXPERTS ARE EXPLORING POTENTIAL WAYS TO WORK DIRECTLY WITH THE BODY’S IMMUNE SYSTEM TO HELP FIGHT CANCERS LIKE METASTATIC MELANOMA.



HERE TO TALK ABOUT MELANOMA, CURRENT NEEDS OF PEOPLE LIVING WITH MELANOMA, THE BURDEN OF THIS DISEASE, RECENT ADVANCEMENTS AND NEW DATA IS MELANOMA CANCER EXPERT DR. STEVEN J. O’DAY, MD, CO-DIRECTOR OF MELANOMA PROGRAM, MELANOMA SPECIALIST, PROFESSOR OF MEDICAL ONCOLOGY, DIRECTOR OF IMMUNO-ONCOLOGY, DIRECTOR OF CLINICAL RESEARCH AT THE JOHN WAYNE CANCER INSTITUTE AT PROVIDENCE SAINT JOHN’S HEALTH CENTER SANTA MONICA, CA.